603102 Stock Overview
Weihai Baihe Biology Technological Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for 603102 from our risk checks.
Weihai Baihe Biology Technological Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥36.16 |
| 52 Week High | CN¥40.50 |
| 52 Week Low | CN¥28.06 |
| Beta | 0.73 |
| 11 Month Change | 6.92% |
| 3 Month Change | 25.34% |
| 1 Year Change | -10.27% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -40.41% |
Recent News & Updates
Shareholder Returns
| 603102 | CN Personal Products | CN Market | |
|---|---|---|---|
| 7D | 7.1% | -2.8% | -2.1% |
| 1Y | -10.3% | -15.9% | 2.8% |
Return vs Industry: 603102 exceeded the CN Personal Products industry which returned -15.9% over the past year.
Return vs Market: 603102 underperformed the CN Market which returned 2.8% over the past year.
Price Volatility
| 603102 volatility | |
|---|---|
| 603102 Average Weekly Movement | 5.5% |
| Personal Products Industry Average Movement | 7.7% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 603102 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603102's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 1,120 | Xinli Liu | www.baiheshengwu.com |
Weihai Baihe Biology Technological Co., Ltd. engages in manufacture and sale of nutrition and healthy food in China and internationally. The company offers health foods, sports nutrition products, and foods for special dietary uses.
Weihai Baihe Biology Technological Co., Ltd. Fundamentals Summary
| 603102 fundamental statistics | |
|---|---|
| Market cap | CN¥2.28b |
| Earnings (TTM) | CN¥157.03m |
| Revenue (TTM) | CN¥845.07m |
14.5x
P/E Ratio2.7x
P/S RatioIs 603102 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603102 income statement (TTM) | |
|---|---|
| Revenue | CN¥845.07m |
| Cost of Revenue | CN¥542.82m |
| Gross Profit | CN¥302.25m |
| Other Expenses | CN¥145.23m |
| Earnings | CN¥157.03m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Nov 29, 2024
| Earnings per share (EPS) | 2.49 |
| Gross Margin | 35.77% |
| Net Profit Margin | 18.58% |
| Debt/Equity Ratio | 0% |
How did 603102 perform over the long term?
See historical performance and comparison